Sustaining Over Three Years of Zero Central Line-Associated Bloodstream Infections with a Multidisciplinary Team Focus and Phased Interventions

Type:

The abstract, which was presented at Association for Vascular Access Annual Scientific Meeting in September 2018, examined the cleaning of needleless connectors and the collection of blood cultures with  3.15% chlorhexidine gluconate (CHG)/70% alcohol (IPA)

ResultsPrevantics® Device Swab trial resulted in a statistically significant reduction in CLABSIs.

Abstract Prevantics Device Swab

Additional Resources

View All